Orthofix achieved Q4 revenue of $219.9 million, showing 2% growth, while significantly reducing its net loss to $2.2 million. The company demonstrated strong operational progress with robust free cash flow of $16.8 million in the quarter and double-digit growth in its Global Spine Fixation business, despite the decision to discontinue the M6 product lines.
Global Spine Fixation net sales grew 10% on a constant currency basis in Q4 2025.
The company generated $16.8 million in free cash flow during the fourth quarter.
Reported net loss improved significantly from $29.1 million in Q4 2024 to $2.2 million in Q4 2025.
The company announced the strategic discontinuation of the M6 artificial cervical and lumbar disc product lines to focus on higher-margin growth.
Orthofix expects continued top-line growth and margin expansion in 2026, targeting revenue between $850 million and $860 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance